mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 3, 2013, Pages

  Rai, Partab ^a   Plagov, Andrei ^a   Lan, Xiqian ^a   Chandel, Nirupama ^a   Singh, Tejinder ^a   Lederman, Rivka ^a   Ayasolla, Kamesh R ^a   Mathieson, Peter W ^b   Saleem, Moin A ^b   Husain, Mohammad ^a   Malhotra, Ashwani ^a   Chander, Praveen N ^c   Singhal, Pravin C ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; mTOR; Oxidative stress; Rapamycin; Renal tubular cells

Indexed keywords

ACTIN; CATALASE; DEOXYGUANOSINE DERIVATIVE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MAMMALIAN TARGET OF RAPAMYCIN; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; RAPAMYCIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL STRESS; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE SILENCING; GLOMERULUS; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY INJURY; KIDNEY PARENCHYMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 84880977590     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00135.2013     Document Type: Article

References (53)

1. Aquilano K, Baldelli S, Pagliei B, Cannata SM, Rotilio G, Ciriolo MR. p53 orchestrates the PGC-1 mediated antioxidant response upon mild redox and metabolic imbalance. Antioxid Redox Signal 18: 386-399, 2013.
2. Atta MG. Diagnosis and natural history of HIV-associated nephropathy. Adv Chronic Kidney Dis 17: 52-58, 2010.
3. Bhaskaran M, Reddy K, Radhakrishanan N, Ding G, Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284: F955-F965, 2003.
4. Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C, Jidar K, Walker-Combrouze F, Peraldi MN, Isnard-Bagnis C, Servais A, Lortholary O, Noël LH, Bollée G. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrol Dial Transplant 27: 1114-1121, 2012.
5. Bjedov I, Partridge L. A longer and healthier life with TOR down regulation: genetics and drugs. Biochem Soc Trans 39: 460-465, 2011.
6. Budanov AV. Stress-responsive sestrins link p53 with redox regulation induced renal hypertrophy. Antioxid Redox Signal 15: 2007. 1679-1690, 2011.
7. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2: 1294-1298, 1989.
8. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, Amendola A, Nardacci R, Métivier D, Este JA, Piacentini M, Kroemer G. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/ FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 194: 1097-1110, 2001.
9. Castedo M, Roumier T, Blanco J, Ferri KF, Barretina J, Tintignac LA, Andreau K, Perfettini JL, Amendola A, Nardacci R, Leduc P, Ingber DE, Druillennec S, Roques B, Leibovitch SA, Vilella-Bach M, Chen J, Este JA, Modjtahedi N, Piacentini M, Kroemer G. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 21: 4070-4080, 2002.
10. Chan KT, Papeta N, Martino J, Zheng Z, Frankel RZ, Klotman PE, D'Agati VD, Lifton RP, Gharavi AG. Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. Kidney Int 75: 366-372, 2009.
11. Droege W. Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine. Pharmacology 46: 61-65, 1993.
12. Durvasula RV, Shankland SJ. Activation of a local renin angiotensin system in podocytes by glucose. Am J Physiol Renal Physiol 294: F830-F839, 2008.
13. Dworkin BM. Selenium deficiency in HIV infection and the acquired deficiency syndrome (AIDS). Chem Biol Interact 91: 181-186, 1994.
14. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 91: 165-180, 1994.
15. Fidelus RK. The generation of oxygen radicals: a positive signal for lymphocyte activation. Cell Immunol 113: 175-182, 1990.
16. Filomeni G, Piccirillo S, Rotilio G, Ciriolo MR. p38MAPK and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y. Biochem Pharmacol 83: 1349-1357, 2012.
17. Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci USA 101: 2488-2493, 2004.
18. Hasty P, Sharp ZD, Curiel TJ, Campisi J. mTORC1 and p53: clash of the gods? Cell Cycle 12: 20-25, 2012.
19. Höpker K, Hagmann H, Khurshid S, Chen S, Schermer B, Benzing T, Reinhardt HC. Putting the brakes on p53-driven apoptosis. Cell Cycle 11: 4122-4128, 2012.
20. Husain M, Meggs LG, Vashistha H, Simoes S, Griffiths KO, Kumar D, Mikulak J, Mathieson PW, Saleem MA, Del Valle L, Pina-Oviedo S, Wang JY, Seshan SV, Malhotra A, Reiss K, Singhal PC. Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem 284: 16648-16658, 2009.
21. Jing K, Song KS, Shin S, Kim N, Jeong S, Oh HR, Park JH, Seo KS, Heo JY, Han J, Park JI, Han C, Wu T, Kweon GR, Park SK, Yoon WH, Hwang BD, Lim K. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 7: 1348-1358, 2011.
22. Kang MY, Kim HB, Piao C, Lee KH, Hyun JW, Chang IY, You HJ. The critical role of catalase in prooxidant and antioxidant function of p53. Cell Death Differ 20: 117-129, 2013.
23. Kobayashi S, Xu X, Chen K, Liang Q. Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury. Autophagy 8: 577-592, 2012.
24. Kondoh H, Lleonart ME, Bernard D, Gil J. Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histol Histopathol 22: 85-90, 2007.
25. Kumar D, Konkimalla S, Yadav A, Sataranatarajan K, Kasinath BS, Chander PN, Singhal PC. HIV-associated nephropathy: role of mammalian target of rapamycin pathway. Am J Pathol 177: 813-821, 2010.
26. Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS. A role for AMP-activated protein kinase in diabetesinduced renal hypertrophy. Am J Physiol Renal Physiol 292: F617-F627, 2007.
27. Lee JH, Kang Y, Khare V, Jin ZY, Kang MY, Yoon Y, Hyun JW, Chung MH, Cho SI, Jun JY, Chang IY, You HJ. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene 29: 1431-1450, 2010.
28. Liu Y, Borchert GL, Surazynski A, Phang JM. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 27: 6729-6737, 2008.
29. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG. The p66Shc adaptor protein controls oxidative stress response and life span in mammals. Nature 42: 309-313, 1999.
30. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer PH. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188: 2033-2045, 1998.
31. Nabel GE, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T-cells. Nature 326: 711-713, 1987.
32. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100: 2112-2116, 2003.
33. Rai P, Plagov A, Kumar D, Pathak S, Ayasolla KR, Chawla AK, Mathieson PW, Saleem MA, Husain M, Malhotra A, Singhal PC. Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN. Exp Mol Pathol 94: 255-261, 2012.
34. Rao TK, Filppone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669-673, 1984.
35. Rehman S, Husain M, Yadav A, Kasinath BS, Malhotra A, Singhal PC. HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway. PLoS One 7: e30071, 2012.
36. Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, Reynoso K, Bargonetti J, Wellstein A, Albanese C, Avantaggiati ML. Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle 11: 4436-4446, 2012.
37. Ross MJ, Martinka S, D'Agati VD, Bruggeman LA. NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol 16: 2403-2411, 2005.
38. Salhan D, Husain M, Subrati A, Goyal R, Singh T, Rai P, Malhotra A, Singhal PC. HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor. Am J Physiol Renal Physiol 303: F503-F514, 2012.
39. Salhan D, Pathak S, Husain M, Tandon P, Kumar D, Malhotra A, Meggs LG, Singhal PC. HIV gene expression deactivates redox-sensitive stress response program in mouse tubular cells both in vitro and in vivo. Am J Physiol Renal Physiol 302: F129-F140, 2012.
40. Sonnerberg A, Carlin G, Akerlund B, Jastrand C. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis 20: 287-290, 1988.
41. Speakman JR, Mitchell SE. Caloric restriction. Mol Aspects Med 32: 159-221, 2011.
42. Staal FJ, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappaB transcription factor. Cell 53: 211-217, 1988.
43. Stanfel MN, Shamieh LS, Kaeberlein M, Kennedy BK. The TOR pathway comes of age. Biochim Biophys Acta 1790: 1067-1074, 2009.
44. Stephensen CB, Marquis GS, Douglas SD, Wilson CM. Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents. J Acquir Immune Defic Syndr 38: 180-190, 2005.
45. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152, 2004.
46. Thakur BK, Chandra A, Dittrich T, Welte K, Chandra P. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway. Biochem Biophys Res Commun 424: 245-250, 2012.
47. Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E, Padura IM, Raker VA, Maccarana M, Petronilli V, Minucci S, Bernardi P, Lanfrancone L, Pelicci PG. A p53-p66Shc signaling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 21: 3872-3878, 2002.
48. Villa-Morales M, Fernández-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 16: 85-101, 2012.
49. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA, Miller RA. Rapamycin slows aging in mice. Aging Cell 11: 675-682, 2012.
50. Won KY, Lim SJ, Kim GY, Kim YW, Han SA, Song JY, Lee DK. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Hum Pathol 43: 221-228, 2012.
51. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 124: 471-84, 2006.
52. Xiao Y, Karnati S, Qian G, Nenicu A, Fan W, Tchatalbachev S, Höland A, Hossain H, Guillou F, Lüers GH, Baumgart-Vogt E. Cre-mediated stress affects sirtuin expression levels, peroxisome biogenesis and metabolism, antioxidant and proinflammatory signaling pathways. PLoS One 7: e41097, 2012.
53. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35, 2011.